Citation Impact
Citing Papers
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
2008 Standout
Predicting Survival in Pulmonary Arterial Hypertension
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Significance of plasma NT-proBNP levels as a biomarker in the assessment of cardiac involvement and pulmonary hypertension in patients with sarcoidosis.
2010
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Right Ventricular Function and Failure
2006
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature
2014
Tadalafil Therapy for Pulmonary Arterial Hypertension
2009 Standout
Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease and Interstitial Lung Diseases
2009
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Prevalence and diagnosis of severe pulmonary hypertension in patients with chronic obstructive pulmonary disease
2007
Idiopathic pulmonary fibrosis
2017 Standout
Outcomes of Pulmonary Endarterectomy Surgery
2006
Pulmonary Hypertension as a Prognostic Indicator at the Initial Evaluation in Idiopathic Pulmonary Fibrosis
2012
Recent Advances in Idiopathic Pulmonary Fibrosis
2007
Acute Phosphodiesterase 5 Inhibition Mimics Hemodynamic Effects of B-Type Natriuretic Peptide and Potentiates B-Type Natriuretic Peptide Effects in Failing But Not Normal Canine Heart
2007
COPD Guidelines: A Review of the 2018 GOLD Report
2018 Standout
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension
2009
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
2006 Standout
Serum N-Terminal Brain Natriuretic Peptide as a Prognostic Parameter in Patients With Pulmonary Hypertension
2006
Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis
2008
Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension
2009
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
2006
Diagnostic value of pleural fluid N‐terminal pro‐brain natriuretic peptide levels in patients with cardiovascular diseases
2008
Pulmonary hypertension in sarcoidosis: A review
2010
Definitions and Diagnosis of Pulmonary Hypertension
2013 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Sildenafil improves hemodynamic parameters in COPD—an investigation of six patients
2005
A global view of pulmonary hypertension
2016 Standout
Significance of Pulmonary Arterial Pressure and Diffusion Capacity of the Lung as Prognosticator in Patients With Idiopathic Pulmonary Fibrosis
2007
Validation of a Method To Screen for Pulmonary Hypertension in Advanced Idiopathic Pulmonary Fibrosis
2008
Pulmonary Hypertension in Chronic Lung Diseases
2013
Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertension
2007
Six-Minute Walk Test and Health Status Assessment in Sarcoidosis
2007
Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: Analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database
2009
Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension
2010
Pulmonary hypertension in chronic lung disease and hypoxia
2018
Pulmonary Hypertension and Cor Pulmonale during Severe Acute Chest Syndrome in Sickle Cell Disease
2008
Pulmonary Endarterectomy: Recent Changes in a Single Institution's Experience of More Than 2,700 Patients
2012
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Early detection of pulmonary arterial hypertension
2014
Changes in causes of death in systemic sclerosis, 1972–2002
2007 Standout
Sarcoidosis
2013 Standout
Bosentan Therapy for Inoperable Chronic Thromboembolic Pulmonary Hypertension
2005
Pulmonary Hypertension in Patients With Idiopathic Pulmonary Fibrosis
2005
Antithrombotic Therapy for VTE Disease
2012 Standout
Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
2007
State-of-the-Art Imaging Techniques in Chronic Thromboembolic Pulmonary Hypertension
2006
Interstitial lung disease guideline
2008
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
2007
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension
2011
Cardiorenal Syndrome
2008 Standout
Lipid-based carriers: manufacturing and applications for pulmonary route
2012
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis
2008
Idiopathic pulmonary fibrosis
2017 Standout
Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension
2009
European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support
2010 Standout
mTOR treatment in lymphangioleiomyomatosis: the role of everolimus
2016
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Pulmonary Hypertension in Patients With Interstitial Lung Diseases
2007
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Sickle-cell disease
2010 Standout
Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
2007
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Liposomes as nanomedical devices
2015 Standout
Idiopathic pulmonary fibrosis
2011 Standout
Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension
2005
The PI3K Pathway in Human Disease
2017 Standout
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Pulmonary hypertension complicating sarcoidosis
2012
Serial Development of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
2008
Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides
2005
Chronic thromboembolic pulmonary hypertension
2014
N-Terminal Pro-B-Type Natriuretic Peptide as an Indicator of Disease Severity in a Heterogeneous Group of Patients With Chronic Precapillary Pulmonary Hypertension
2006
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
The Acutely Decompensated Right Ventricle
2005
Can brain natriuretic peptide predict outcome after cardiac arrest? An observational study
2007
Pulmonary hypertension in COPD
2008
An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease
2012 Standout
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology
2009
Procoagulant Membrane Microparticles Correlate with the Severity of Pulmonary Arterial Hypertension
2007
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways
2016
Characteristics and Outcome After Hospitalization for Acute Right Heart Failure in Patients With Pulmonary Arterial Hypertension
2011
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Sarcoidosis-Associated Pulmonary Hypertension
2017
Pulmonary Arterial Hypertension
2006
Chronic Heart Failure in Congenital Heart Disease
2016
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Pulmonary Diseases and the Heart
2007
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension
2008
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Pulmonary Hypertension in Patients With Interstitial Lung Diseases
2007
Association of Serum Creatinine With Abnormal Hemodynamics and Mortality in Pulmonary Arterial Hypertension
2008
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Global burden of heart failure: a comprehensive and updated review of epidemiology
2022 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
N-Terminal Pro–B-Type Natriuretic Peptide Levels for Dynamic Risk Stratification of Patients With Acute Coronary Syndromes
2004
Works of Rainer Baumgartner being referenced
Lung Deposition of a Liposomal Cyclosporine A Inhalation Solution in Patients after Lung Transplantation
2009
Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
2011
Potential functional and survival benefit of double over single lung transplantation for selected patients with idiopathic pulmonary fibrosis
2010
Clinical significance of brain natriuretic peptide in primary pulmonary hypertension
2004
Characterization of Brain Natriuretic Peptide in Long-term Follow-up of Pulmonary Arterial Hypertension
2005
Hemodynamic Response to Sildenafil, Nitric Oxide, and Iloprost in Primary Pulmonary Hypertension
2004
N-terminal Pro-Brain Natriuretic Peptide and Renal Insufficiency as Predictors of Mortality in Pulmonary Hypertension
2007
Pulmonary Arterial Hypertension: Diagnosis with Fast Perfusion MR Imaging and High-Spatial-Resolution MR Angiography—Preliminary Experience
2005
Brain Natriuretic Peptide and Exercise Capacity in Lung Fibrosis and Pulmonary Hypertension
2004
Brain Natriuretic Peptide Is a Prognostic Parameter in Chronic Lung Disease
2006